Translation Acceleration Grant
Translation Acceleration Grants
Prostate Cancer Canada (PCC) has invited applications for investigator-initiated Translation Acceleration Grants (TAG) that address a significant issue in the management of prostate cancer, with a high potential of preventing disease progression and/or improving quality of life in the short term.
Starting in 2014, each competition has addressed a significant issue in the management of prostate cancer. The intent of the program is not to support new discovery. Rather the grants should leverage existing knowledge and capabilities to accelerate impact without overlapping currently funded Prostate Cancer Canada and Movember foundation initiatives.
: Aggressive vs. indolent prostate cancer
: Novel therapeutics for aggressive disease
True Nth Survivorship Grants (TAG3
: Innovative approaches to manage prostate cancer
These opportunities were awarded by Prostate Cancer Canada and proudly funded in part by the Movember Foundation.
See Funded Project Database for information on funded grants.